Entera Bio raises $275m for Phase III osteoporosis drug trial
Israeli drug development company Entera Bio (Nasdaq: ENTX) has announced a $275 million private placement. Prior to the announcement ...
Sunday, September 6, 2026
Tag: 275M
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.